News & Media

Dr. Jessica Moe leads a research study to identify clinical subgroups of low-risk frequent users

Canadians spent $6,299 per capita on healthcare in 2016, with emergency department (ED) expenses accounting for an increasing proportion of costs. Policy makers have identified frequent ED users as incurring disproportionately high healthcare costs due to high use of ED and other health services, while clinicians consider them high-risk patients.

Dr. Jessica Moe, an Emergency Physician at Vancouver General Hospital and Assistant Professor at the University of British Columbia, is leading a research study to identify distinct clinical subgroups of low-risk frequent users, to develop interventions specifically targeting identified subgroups to redirect care to lower cost settings.

“By carefully characterising these groups, our team will have a higher likelihood of developing successful interventions,” says Dr. Moe. “We are using an innovative approach to precisely identify clinically important patient subgroups with distinct characteristics and visit patterns. Our methodology also allows us to identify previously unanticipated subgroups.”

Future plans for the research team include: engaging with patient and allied health partners; recruiting additional patients to provide the perspectives of each clinical subgroup; and using qualitative methods to explore the development and modes of pilot-implementing and evaluating each intervention developed.

To read the full article on the Population Data BC (PopData) website, visit here: https://www.popdata.bc.ca/news/project_approval_18-139

Canadian Centre for Substance Use and Addiction (CCSA) Research Conference

Our Research Manager, Seth Long, presents at the 2023 Canadian Centre for Substance Use and Addiction (CCSA) Research Conference on behalf of the Evaluating Microdosing in the Emergency Department: A randomized controlled trial of buprenorphine/naloxone (EMED) study.

EMED Study at the BCCDC Research Symposium

Our very own EMED study team member, Khushi Dabla, presents the Evaluating Microdosing in the Emergency Department (EMED): A randomized controlled trial of buprenorphine/naloxone study to fellow researchers at the 2023 BCCDC Research Symposium. To find more research from the BC Centre for Disease Control (BCCDC), visit here: http://www.bccdc.ca/our-research

REBEL Cast Ep117: Low Dose vs Standard Dose Take-Home Buprenorphine From the ED

REBEL EM stands for Rational Evidence Based Evaluation of Literature in Emergency Medicine.  They cover a myriad of topics, primarily focusing on evidence-based clinical topics.

At its core, evidence-based medicine (EBM) incorporates clinical judgment, relevant scientific evidence, and patient values/preferences. Research and scientific evidence help inform care but should not dictate care of patients.

With the constant influx of new published research, it makes it difficult to stay current with the latest and greatest. REBEL EM was created October 2013 in an effort to cut down knowledge translation of research to clinical application (Bench to Bedside), using a structured critical appraisal method of evaluation.

Source: https://rebelem.com/about-us/

REBEL Cast Ep117: Low-Dose vs Standard-Dose Take Home Buprenorphine From the ED features Dr. Jessica Moe’s Microdosing and standard‐dosing take‐home buprenorphine from the Emergency Department: A feasibility study where Dr. Tara Persaud Holmes (MD, MBA) and Dr. Cara Borelli (DO) discuss study findings and the importance of feasible addiction care in the emergency department.

Find blog audio and full episode here: https://rebelem.com/rebel-cast-ep117-low-dose-vs-standard-dose-take-home-buprenorphine-from-the-ed/

Small Steps, Big Idea funding paves way for project successes

The Small Steps, Big Idea initiative provides funding for VPSA members to develop concepts that engage physicians and their colleagues, improve patient care, develop better communication, and/or build relationships across specialties, departments, health authority leadership, and community members. Funding can be used for sessional payments, meals, venue costs, and/or speaker or consultant fees.

Three projects conducted over the 2022/23 fiscal year serve as inspirational examples, including our very own EMED study spearheaded by Dr. Jessica Moe.

Dr. Jessica Moe has used Small Steps, Big Idea funding for two phases of her project entitled Understanding Healthcare Provider and Patient Experiences with Emergency Department Suboxone. The latest funding was used to build on the enthusiasm and momentum built during the launch of the VGH Emergency Department’s Suboxone program in 2019.

“We were a multidisciplinary team, and we developed an iterative, concerted engagement plan,” said Dr. Moe. “During activities, we intentionally incorporated opportunities for clinicians to provide feedback about our Suboxone program. We then incorporated this feedback into the next rounds of engagement activities to ensure we were continually responsive to providers’ needs.”

Dr. Moe and her team are proud to have met their program objectives and desired outcomes. They attribute their success to intentionally incorporating multidisciplinary feedback into their program processes, and their flexibility to adapt to identified needs.

“My team and I are incredibly grateful for VPSA’s support, which enabled this important work,” said Dr. Moe. “We’re currently building capacity in our health-care provider group to take shared ownership of our Suboxone program and drive and shape it into the future. We continue to advocate for more institutional and regional support of our program at meetings that include VGH and VCH leadership to enable our continuation beyond the project period.”

To read the full article from the Vancouver Medical, Dental and Allied Staff Association (VMDAS) and Vancouver Physician Staff Association (VPSA), visit here: Small Steps, Big Idea funding paves way for project successes.

Health Canada announces $11.78 million in funding to help support people who use substances in British Columbia 

To help support the response to the overdose crisis and address harms related to substance use and the toxic illegal drug supply, over the last two years, the Government of Canada has dedicated over $182 million to Health Canada’s Substance Use and Addictions Program (SUAP), and recently proposed another $100 million through Budget 2022. $11.78 million in funding has been granted to 14 innovative community-led projects in British Columbia.  

With this funding, these projects will help to improve health outcomes for people who are at risk of experiencing substance-related harms and overdose by scaling up prevention, harm reduction and treatment efforts across British Columbia.

Dr. Jessica Moe and team have received $1,168,342 to expand access to buprenorphine/naloxone for people with opioid use disorders who present to Emergency Departments with a variety of clinical presentations. This additional funding will expand the program to two more emergency department sites (St. Paul’s Hospital in Vancouver’s Downtown Eastside and North-East Health Centre in Edmonton). This is in addition to the $1,289,296 the project has already received from SUAP, which you can find at this previous post.

Funding is provided through the Substance Use and Addictions Program (SUAP), which supports evidence-informed and innovative initiatives across a range of interventions—health promotion, prevention, harm reduction and treatment—targeting a broad range of legal and illegal substances.

Find more

VPSA Project funding helps improve Emergency Department Suboxone Program

A multidisciplinary team at VGH’s Emergency Department has been screening patients for opioid use disorder since 2019. Eligible patients receive take-home Suboxone packages. (Suboxone is a first-line opioid agonist therapy in BC; there is evidence for its effectiveness when provided in emergency department settings.)

“We wanted to gather feedback from the many care providers involved in the program as well as from patients to understand which aspects of our program had been successful,” said Dr. Jessica Moe, a VGH emergency physician and assistant professor. “We applied for funding from VPSA’s Small Steps, Big Idea to find out how we could optimize our processes and make improvements.”

One phased project is Understanding Healthcare Provider and Patient Experiences with Emergency Department Suboxone led by Dr. Jessica Moe. Phase 2 of the project is gathering stakeholder feedback, while also prioritizing planning for sustainability. Dr. Moe is engaging with leaders at the department, hospital, and regional levels to share program successes along with valuable patient and provider feedback. This helps her advocate for improved point-of-care, patient-centred addictions services in the VGH Emergency Department. The current VPSA funding is also being used to build key relationships as well as infrastructure and patient and provider supports that will allow the Suboxone program to be sustained into the future.

To read the full article, visit: https://ourvancouvermsa.ca/2021/10/08/vpsa-project-funding-helps-improve-emergency-department-suboxone-program/

To read all of the Small Steps, Big Idea funds new initiatives, visit: https://ourvancouvermsa.ca/2022/11/03/small-steps-big-idea-funding-helps-take-projects-to-the-next-level/

Launching our Moe Lab Website

We’re happy to announce the launch of our research team’s website: the Moe Lab. We are a research team at the University of British Columbia Department of Emergency Medicine. Our studies currently operate out of the Vancouver General Hospital and St. Paul’s Hospital campus locations. For more information on our research and team, visit the “Research” and “Our Team” subpages!

Introducing the Moe Lab Research Team

You can learn more about our amazing research team on “Our Team” page or click here.

Dr. Jessica Moe among others faculty members at BCCDC awarded up to $100,000 per annum

From 2014 to 2019, the BCCDC Foundation for Public Health ran a pilot funding program called the Open Awards Program (OAP). The purpose of the OAP was to strengthen the research enterprise at the BC Centre for Disease Control (BCCDC) by providing small pilot grants and seed funding to support research, knowledge translation, and convening activities that would enable researchers to secure larger funding awards. Spread over two competitions per year, we awarded up to $100,000 per annum to faculty members at the BCCDC, many of whom went on to secure grants from larger funding sources. Among other recipients, Dr. Jessica Moe was awarded to her research for Buprenorphine/naloxone Standard Dosing and Microdosing in the Emergency Department: A feasibility study (2019).

To read the full article on the BCCDC Foundation website, please visit: https://bccdcfoundation.org/reducing-harms-seed-and-pilot-funding-for-bccdc-researchers/